Private Label Skin Care Inc.June 23, 2025

FDA 483 - Private Label Skin Care Inc. - June 23, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Private Label Skin Care Inc.

Record Details

An FDA inspection of Private Label Skin Care Inc. in Canoga Park, CA, revealed significant quality control failures. The firm continued to distribute OTC drug products contaminated with benzene, a known carcinogen, after receiving test results indicating levels above acceptable limits. Additionally, the company failed to conduct proper investigations into these discrepancies and lacked established annual product review procedures for its OTC drug products.

Company: Private Label Skin Care Inc.
Inspection Date: June 23, 2025
Product Type: Drugs
Office: Division of Pharmaceutical Quality Operations IV
Person: Anney Lin (Statistical Science Director)

Open in Dashboard

ID · 09968422-caf4-4057-af90-622c175e4325